John Stuart Patton - Net Worth and Insider Trading
John Stuart Patton Net Worth
The estimated net worth of John Stuart Patton is at least $11 Million dollars as of 2024-11-13. John Stuart Patton is the Director of Halozyme Therapeutics Inc and owns about 179,876 shares of Halozyme Therapeutics Inc (HALO) stock worth over $11 Million. John Stuart Patton is also the Chief Scientific Officer, Director of Nektar Therapeutics and owns about 313,880 shares of Nektar Therapeutics (NKTR) stock worth over $414,322. Details can be seen in John Stuart Patton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Stuart Patton has not made any transactions after 2014-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Stuart Patton
John Stuart Patton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Stuart Patton owns 2 companies in total, including Halozyme Therapeutics Inc (HALO) , and Nektar Therapeutics (NKTR) .
Click here to see the complete history of John Stuart Patton’s form 4 insider trades.
Insider Ownership Summary of John Stuart Patton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2014-08-19 | director |
| NKTR | Nektar Therapeutics | 2008-11-14 | director & Chief Scientific Officer |
John Stuart Patton Latest Holdings Summary
John Stuart Patton currently owns a total of 2 stocks. Among these stocks, John Stuart Patton owns 179,876 shares of Halozyme Therapeutics Inc (HALO) as of August 19, 2014, with a value of $11 Million and a weighting of 96.28%. John Stuart Patton also owns 313,880 shares of Nektar Therapeutics (NKTR) as of November 14, 2008, with a value of $414,322 and a weighting of 3.72%.
Latest Holdings of John Stuart Patton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2014-08-19 | 179,876 | 59.64 | 10,727,805 |
| NKTR | Nektar Therapeutics | 2008-11-14 | 313,880 | 1.32 | 414,322 |
Holding Weightings of John Stuart Patton
John Stuart Patton Form 4 Trading Tracker
According to the SEC Form 4 filings, John Stuart Patton has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the sale of 75,000 shares on August 19, 2014, which brought John Stuart Patton around $747,000.
According to the SEC Form 4 filings, John Stuart Patton has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the sale of 760 shares on November 14, 2008, which brought John Stuart Patton around $3,321.
Insider Trading History of John Stuart Patton
- 1
John Stuart Patton Trading Performance
John Stuart Patton Ownership Network
Ownership Network List of John Stuart Patton
Ownership Network Relation of John Stuart Patton
John Stuart Patton Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
John Stuart Patton is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, John Stuart Patton made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
John Stuart Patton Mailing Address
Above is the net worth, insider trading, and ownership report for John Stuart Patton. You might contact John Stuart Patton via mailing address: 150 Industrial Road, C/o Nektar Therapeutics, San Carlos Ca 94070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
